Original Source(s)
Related Content
GLP-1 Drugs Linked to GI Effects, Uncertain Signals
Umbrella review evaluates over 1,700 trials to assess noncardiometabolic outcomes beyond weight and glycemic effects.
April 16, 2026
-
3 min